SCHEMBL8971814

SCHEMBL8971814

COc1ccccc1OC(CCNN)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 13/20 0.76
SLC6A4 P31645 12/20 0.76
CYP2D6 P10635 5/20 0.76
CYP1A2 P05177 4/20 0.76
CYP3A4 P08684 4/20 0.76
TSHR P16473 3/20 0.76
SLC6A3 Q01959 3/20 0.76
KMT2A Q03164 2/20 0.76
MEN1 O00255 1/20 0.76
CYP2C19 P33261 1/20 0.76
PMP22 Q01453 2/20 0.74
CHRM1 P11229 2/20 0.55
ADRA2B P18089 2/20 0.55
HTR2A P28223 2/20 0.55
HTR2C P28335 2/20 0.55
HRH1 P35367 2/20 0.55
OPRM1 P35372 2/20 0.55
DRD3 P35462 2/20 0.55
OPRK1 P41145 2/20 0.55
HTR2B P41595 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nisoxetine SCHEMBL30026153 0.86 SLC6A4 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL3897550 0.86 SLC6A4 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL124289 0.86 SLC6A4 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL3892886 0.86 SLC6A4 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL29401038 0.86 SLC6A4 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
SCHEMBL8971047 0.85 SLC6A4 (0.76) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
SCHEMBL5309993 0.85 SLC6A2 (0.76) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL467262 0.85 SLC6A2 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL29440249 0.85 SLC6A2 (1.00) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4
Nisoxetine SCHEMBL14973458 0.84 SLC6A4 (0.94) SLC6A2SLC6A4CYP2D6CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545425-B1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-03-20 EP disclosed
US-5268468-A Or optical isomers thereof HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-12-07 US disclosed
US-5229417-A Obsessive compulsive disorders HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-07-20 US disclosed
EP-0545425-A1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-06-09 EP disclosed